Pro Share Advisors LLC Karuna Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$161.01 - $317.85 $151,832 - $299,732	943 Added 38.29%	3,406 $1.08 Million
Q3 2023 Nov 13, 2023	BUY	$164.66 - $218.08 $6,751 - $8,941	41 Added 1.69%	2,463 $416,000
Q2 2023 Aug 10, 2023	SELL	$176.32 - $240.22 $668,429 - $910,674	-3,791 Reduced 61.02%	2,422 $525,000
Q1 2023 May 11, 2023	SELL	$161.33 - $204.36 $83,730 - $106,062	-519 Reduced 7.71%	6,213 $1.13 Million
Q4 2022 Feb 02, 2023	BUY	$191.53 - $236.82 $111,470 - $137,829	582 Added 9.46%	6,732 $1.32 Million
Q3 2022 Nov 04, 2022	BUY	$123.79 - $277.42 $107,821 - $241,632	871 Added 16.5%	6,150 $1.38 Million
Q2 2022 Aug 01, 2022	SELL	$93.97 - $143.33 $185,026 - $282,216	-1,969 Reduced 27.17%	5,279 $667,000
Q1 2022 May 10, 2022	SELL	$98.9 - $132.37 $174,954 - $234,162	-1,769 Reduced 19.62%	7,248 $918,000
Q4 2021 Feb 08, 2022	SELL	$110.64 - $159.4 $15,710 - $22,634	-142 Reduced 1.55%	9,017 $1.18 Million
Q3 2021 Nov 12, 2021	SELL	$101.2 - $125.87 $191,672 - $238,397	-1,894 Reduced 17.14%	9,159 $1.12 Million
Q2 2021 Aug 13, 2021	BUY	$107.45 - $135.95 $332,342 - $420,493	3,093 Added 38.86%	11,053 $1.26 Million
Q1 2021 May 14, 2021	BUY	$95.46 - $133.08 $30,929 - $43,117	324 Added 4.24%	7,960 $957,000
Q4 2020 Feb 09, 2021	BUY	$75.23 - $109.23 $106,299 - $154,341	1,413 Added 22.71%	7,636 $776,000
Q3 2020 Nov 13, 2020	SELL	$71.31 - $109.74 $4,207 - $6,474	-59 Reduced 0.94%	6,223 $481,000
Q2 2020 Aug 03, 2020	BUY	$62.14 - $117.21 $129,437 - $244,148	2,083 Added 49.61%	6,282 $700,000
Q1 2020 May 15, 2020	SELL	$60.41 - $115.92 $123,719 - $237,404	-2,048 Reduced 32.78%	4,199 $302,000
Q4 2019 Feb 12, 2020	BUY	$11.44 - $123.99 $71,465 - $774,565	6,247 New	6,247 $471,000

Others Institutions Holding KRTX

# of Institutions

Shares Held

332K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account